Skip to main content
. 2022 Nov 4;141(7):766–786. doi: 10.1182/blood.2022017046

Figure 5.

Figure 5.

Figure 5.

C1Q+Molm13 cells are highly infiltrative toward tissue fibroblasts. (A) Flow cytometry sorting of Molm13 based on expression of C1Q. (B-C) Transwell migration assay of Molm13C1Q+ and Molm13C1Q−, or Molm13 cocultured with HaCaT, skin fibroblasts, or GI fibroblasts. (D) qPCR analysis of C1QA in Molm13 cells upon depletion of C1QA through shRNA (shC1QA-1 and shC1QA-2). (E) Transwell migration assay of Molm13 cells upon C1QA depletion. (F) NSG mice were injected with one million of Molm13C1Q+ or Molm13C1Q− cells and metastasis nodules in skin and intestine are numbered and shown. (G) Number or size of skin or GI nodules were calculated. (H-I) qPCR analysis of C1QA (H) and TGF-β1, TGF-β2, and TGF-β3 (I) in Molm13C1Q+ and Molm13C1Q− cells. (J) qPCR analysis of TGF-β1, TGF-β2, and TGF-β3 in Molm13C1Q+ cells cocultured with or without fibroblasts. (K) Western blot analysis of TGF-β1 of Molm13C1Q+ and Molm13C1Q− cells cocultured with or without fibroblasts. (L) Transwell migration assay of Molm13C1Q+ cells upon skin fibroblast coculture and TGF-β1 inhibitor galunisertib treatment.